STOCK TITAN

Vitanova Life Sciences (VNOV) Stock Price, News & Analysis

VNOV OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
9 14 sessions, April 20, 2026 to October 30, 2026
Largest daily move
+44% close of October 15, 2026

Company Description

Vitanova Life Sciences (OTC: VNOV) is classified in the packaged foods industry within the Consumer Defensive sector and carries a market capitalization of $23.6M.

VNOV has declined 39.9% over the past week. The last closing price was $2.83.

For FY2026, Vitanova Life Sciences reported revenue of $3.0M with net income of -$37K. The company operates at a net profit margin of -1.2%.

This page collects what Stock Titan holds for VNOV, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$2.83
-5.83%
-0.17
Last updated: October 30, 2026 at 16:00
-39.9%
Performance 1 week
$23.6M

Vitanova Life Sciences (VNOV) closed at $2.83 on October 30, 2026. Over the past week, the price has lost 39.9%.

See what a $1,000 investment in VNOV would be worth today

Average down calculator for VNOV

VNOV Metrics & Rankings

Market Cap
$23.6M
View ranking

Price returns through October 30, 2026. Ranking links may use different dates.

Latest News

No recent news available for VNOV.

SEC Filings

Vitanova Life Sciences has filed 4 recent SEC filings, including 2 Form 10-Q, 1 Form 10-K, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VNOV SEC filings →

Financial Highlights

Vitanova Life Sciences generated $3.0M in revenue in FY2026, retaining a 30.1% gross margin, operating income reached $4K (0.1% operating margin), and net income was -$37K, reflecting a -1.2% net profit margin. The company generated $814K in operating cash flow. The current ratio was 6.14, measuring current assets divided by current liabilities.

$3.0M
Revenue (FY2026)
-$37K
Net Income (FY2026)
$814K
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for VNOV.

Short Interest History

Last 12 Months

Short interest in Vitanova Life Sciences (VNOV) currently stands at 33 shares, representing 0.0% of the float.

Days to Cover History

Last 12 Months

Days to cover for Vitanova Life Sciences (VNOV) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since April 2026, the figure has increased by 99899%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

VNOV Company Profile & Sector Positioning

Vitanova Life Sciences (VNOV) operates in the Packaged Foods industry within the broader Consumer Defensive sector and is listed on the OTC.

Investors comparing VNOV often look at related companies in the same sector, including Starco Brands Inc (STCB), Steakholder Foods Ltd (MTTCF), Nepra Foods Inc (NPRFF), Cellev8 Nutrition Inc (CELV), and Harvard Apprats REG TCH (HRGN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VNOV's relative position within its industry.

Frequently Asked Questions

The current stock price of Vitanova Life Sciences (VNOV) is $2.83 as of October 30, 2026.

The market cap of Vitanova Life Sciences (VNOV) is approximately $23.6M. Learn more about what market capitalization means .

The FY2026 revenue of Vitanova Life Sciences (VNOV) is $3.0M, from its most recent completed fiscal year.

The FY2026 net income of Vitanova Life Sciences (VNOV) is -$37K, from its most recent completed fiscal year.

The operating cash flow of Vitanova Life Sciences (VNOV) is $814K for FY2026, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Vitanova Life Sciences (VNOV) is -1.2% for FY2026, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Vitanova Life Sciences (VNOV) is 0.1% for FY2026, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Vitanova Life Sciences (VNOV) is 30.1% for FY2026, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Vitanova Life Sciences (VNOV), current assets divided by current liabilities, was 6.14 at the end of FY2026, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Vitanova Life Sciences (VNOV) is $911K for FY2026, its most recent completed fiscal year.

The operating income of Vitanova Life Sciences (VNOV) is $4K for FY2026, its most recent completed fiscal year. Learn about operating income.